Innovative Device Technologies

Innovative Device Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Innovative Device Technologies is a private, revenue-generating medical device services and manufacturing company founded in 2008. Operating as a contract development and manufacturing organization (CDMO), it leverages its engineering and regulatory expertise to help clients bring specialized medical devices to market. Its competitive advantages include flexible project management, customer-owned IP, and a well-equipped product development lab in Silicon Valley (Fremont, CA). The company has a broad portfolio of product experience across several high-growth medical device sectors.

NeurovascularCardiovascularGastroenterologyUrology

Technology Platform

Integrated medical device CDMO service platform offering mechanical design, electrical/software integration, prototyping (3D printing, injection molding), electromechanical assembly, and V&V testing within a quality management system.

Opportunities

The growing trend of outsourcing in the medtech industry, especially from capital-efficient startups, provides a steady stream of potential clients.
Deepening expertise in high-value areas like neurovascular and minimally invasive surgery can command premium service rates.
Geographic location in Silicon Valley offers direct access to a hub of innovation and venture capital.

Risk Factors

Revenue is contingent on the funding and success of client companies, creating cyclical vulnerability.
Intense competition from larger, global CDMOs could pressure margins and client acquisition.
Operational risks include failure to meet client timelines or regulatory standards, which could severely damage reputation in a niche industry.

Competitive Landscape

IDT competes in the fragmented medical device CDMO market against large players like Jabil, Flex, and Integer, as well as numerous specialized smaller firms. Its differentiation lies in its focus on complex interventional devices, full-service capabilities from concept to transfer, and stated flexibility for client needs. Success depends on executional excellence and niche expertise rather than scale.